- Cancer Epigenetics
-
Chang DK
- KMID: 1113291
- Korean J Gastroenterol.
- 2004 Jul;44(1):1-12.
Knowledge regarding molecular events of cancer development has been rapidly accumulated during the last decade. The discovery of tumor suppressor gene-silencing by aberrant promoter CpG island hypermethylation and histone-directed chromatin... -
- CITED
-
- Close
- SHARE
-
- Close
- Lack of Aberrant Methylation in an Adjacent Area of Left-Sided Colorectal Cancer
-
Sambuudash O, Kim HS, Cho MY
- KMID: 2419080
- Yonsei Med J.
- 2017 Jul;58(4):749-755.
- doi: 10.3349/ymj.2017.58.4.749
PURPOSE: The molecular nature and the rate-limiting step of epigenetic field defects in the evolution of left-sided colorectal cancer (LCA) remain uncertain. MATERIALS AND METHODS: The methylation status of 27 candidate... -
- CITED
-
- Close
- SHARE
-
- Close
- Biomarkers for Colorectal Cancer Treatment
-
Suk KT, Kim HS
- KMID: 1062808
- Korean J Gastroenterol.
- 2009 Feb;53(2):68-75.
Individualized tailored therapy is a currently pursuing direction for improving the outcome of patients with colorectal cancer. Targeted therapy is the potential strategy to reach this goal by evaluating status... -
- CITED
-
- Close
- SHARE
-
- Close
